Back to Results
First PageMeta Content
Ribbon symbolism / Oncotype DX / Breast cancer / Tamoxifen / Adjuvant therapy / HER2/neu / Chemotherapy / Medicine / Cancer treatments / Oncology


Microsoft Word[removed]PSD - MSACPSD-Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease re
Add to Reading List

Document Date: 2015-04-16 01:49:35

Open Document

File Size: 58,15 KB

Share Result on Facebook

Company

Specialised Therapeutics Australia / MSAC / Genomic Health Inc. / /

Country

United States / Canada / Australia / United Kingdom / Ireland / /

Currency

pence / USD / /

Event

Reorganization / /

Facility

USA laboratory / Genomic Health laboratory / College of American Pathologists / California-based Genomic Health laboratory / /

Holiday

Commonwealth Day / /

IndustryTerm

particular / health care services / risk / important tool / formal algorithms / health insurance / low risk groups / treatment algorithm / predictive tool / /

MedicalCondition

early breast cancer / international breast cancer / DX breast cancer / breast cancer / cancer / disease / tumour / invasive breast cancer / patient’s breast cancer / /

MedicalTreatment

adjuvant chemotherapy / endocrine therapy / chemotherapy / hormone therapy / surgery / hormonal therapy / /

Organization

College of American Pathologists / Therapeutic Goods Administration / National Association of Testing Authorities / Medicare / Medical Service / /

Person

Feedback Feedback / /

Position

driver / Minister / Consumer/Consultant / Governor / /

Product

anastrozole / /

ProvinceOrState

California / /

Technology

treatment algorithm / Gene expression / chemotherapy / /

URL

www.msac.gov.au / /

SocialTag